Cadrenal Therapeutics, Inc. SEC filings CVKD
Cadrenal Therapeutics, Inc. has 277 filings in SEC EDGAR's recent list, going back to Jul 15, 2022. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 7, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 13, 2026 | Oct 9, 2026 |
| 4 | Insider transaction | Oct 13, 2026 | Oct 9, 2026 |
| 4 | Insider transaction | Oct 13, 2026 | Oct 9, 2026 |
| 4 | Insider transaction | Oct 13, 2026 | Oct 9, 2026 |
| 4 | Insider transaction | Oct 13, 2026 | Oct 9, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 25, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 144 | Notice of proposed sale | Jun 15, 2026 | — |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | May 29, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 11, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 22, 2026 |
| 144 | Notice of proposed sale | May 11, 2026 | — |
| 4 | Insider transaction | Dec 31, 2025 | Dec 29, 2025 |
| 144 | Notice of proposed sale | Dec 29, 2025 | — |
| 4 | Insider transaction | Dec 3, 2025 | Dec 2, 2025 |
| 3 | Initial insider ownership | Dec 3, 2025 | Nov 24, 2025 |
| 4 | Insider transaction | Oct 28, 2025 | Oct 24, 2025 |
| 4 | Insider transaction | Oct 28, 2025 | Oct 24, 2025 |
| 144 | Notice of proposed sale | Oct 27, 2025 | — |
| 144 | Notice of proposed sale | Oct 27, 2025 | — |
| 144 | Notice of proposed sale | Oct 24, 2025 | — |
| 144 | Notice of proposed sale | Oct 24, 2025 | — |
| 4 | Insider transaction | Oct 14, 2025 | Oct 9, 2025 |
| 4 | Insider transaction | Oct 14, 2025 | Oct 9, 2025 |
| 144 | Notice of proposed sale | Oct 14, 2025 | — |
| 144 | Notice of proposed sale | Oct 14, 2025 | — |
| 144 | Notice of proposed sale | Oct 9, 2025 | — |
| 144 | Notice of proposed sale | Oct 9, 2025 | — |
| 4 | Insider transaction | Oct 7, 2025 | Oct 6, 2025 |
| 144 | Notice of proposed sale | Oct 6, 2025 | — |
| 4 | Insider transaction | Oct 3, 2025 | Oct 2, 2025 |
| 144 | Notice of proposed sale | Oct 2, 2025 | — |
| 4 | Insider transaction | Oct 1, 2025 | Sep 29, 2025 |
| 4 | Insider transaction | Oct 1, 2025 | Sep 29, 2025 |
| 144 | Notice of proposed sale | Oct 1, 2025 | — |
| 144 | Notice of proposed sale | Oct 1, 2025 | — |
| 144 | Notice of proposed sale | Sep 29, 2025 | — |
| 144 | Notice of proposed sale | Sep 29, 2025 | — |
| 144/A | Filing | Sep 29, 2025 | — |
| 4 | Insider transaction | Sep 26, 2025 | Sep 24, 2025 |
| 4 | Insider transaction | Sep 26, 2025 | Sep 24, 2025 |
| 144 | Notice of proposed sale | Sep 25, 2025 | — |
| 144 | Notice of proposed sale | Sep 25, 2025 | — |
| 144 | Notice of proposed sale | Sep 24, 2025 | — |
| 144 | Notice of proposed sale | Sep 24, 2025 | — |
| 4 | Insider transaction | Aug 29, 2025 | Aug 27, 2025 |
| 4 | Insider transaction | Aug 29, 2025 | Aug 27, 2025 |
| 144 | Notice of proposed sale | Aug 28, 2025 | — |
| 144 | Notice of proposed sale | Aug 28, 2025 | — |
| 144 | Notice of proposed sale | Aug 27, 2025 | — |
| 144/A | Filing | Aug 27, 2025 | — |
| 144 | Notice of proposed sale | Aug 27, 2025 | — |
| 4/A | Ownership document | Mar 24, 2025 | Jan 23, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 4 | Insider transaction | Feb 6, 2025 | Feb 5, 2025 |
| 3 | Initial insider ownership | Feb 6, 2025 | Feb 5, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Jan 29, 2025 | — |
| 4 | Insider transaction | Jan 24, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 23, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 15, 2025 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 4, 2024 | — |
| 4 | Insider transaction | Apr 10, 2024 | Apr 10, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Apr 2, 2024 |
| 3 | Initial insider ownership | Apr 3, 2024 | Feb 7, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 12, 2024 | — |
| 4 | Insider transaction | Feb 12, 2024 | Oct 23, 2023 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Oct 6, 2023 | Oct 4, 2023 |
| 4 | Insider transaction | Sep 6, 2023 | Sep 5, 2023 |
| 4 | Insider transaction | Sep 5, 2023 | Sep 1, 2023 |
| 4 | Insider transaction | Jul 24, 2023 | Jul 23, 2023 |
| 3 | Initial insider ownership | Jul 24, 2023 | Jul 23, 2023 |
| 3/A | Filing | Mar 31, 2023 | Jan 19, 2023 |
| SC 13G | Ownership over 5% (passive) | Mar 27, 2023 | — |
| 4 | Insider transaction | Mar 22, 2023 | Mar 21, 2023 |
| 4 | Insider transaction | Mar 16, 2023 | Mar 16, 2023 |
| 4 | Insider transaction | Feb 13, 2023 | Feb 10, 2023 |
| 4 | Insider transaction | Jan 24, 2023 | Jan 24, 2023 |
| 4 | Insider transaction | Jan 24, 2023 | Jan 24, 2023 |
| 4 | Insider transaction | Jan 24, 2023 | Jan 24, 2023 |
| 3 | Initial insider ownership | Jan 19, 2023 | Jan 19, 2023 |
| 3 | Initial insider ownership | Jan 19, 2023 | Jan 19, 2023 |
| 3 | Initial insider ownership | Jan 19, 2023 | Jan 19, 2023 |
| 3 | Initial insider ownership | Jan 19, 2023 | Jan 19, 2023 |
| 3 | Initial insider ownership | Jan 19, 2023 | Jan 19, 2023 |
| 3 | Initial insider ownership | Jan 19, 2023 | Jan 19, 2023 |
Showing 106 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CVKD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Ponte Vedra, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1937993
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.